|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Trade accounts receivable | ||||||||||||||||||||
| Allowance for credit losses | ||||||||||||||||||||
| Trade accounts receivable, net | ||||||||||||||||||||
| Other receivables | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Equipment and leasehold improvements, net | ||||||||||||||||||||
| Operating leases, right of use | ||||||||||||||||||||
| Other assets, net | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Line of credit – accounts receivable, related party | ||||||||||||||||||||
| Line of credit – inventory, related party | ||||||||||||||||||||
| Current portion of line of credit, inventory, related party | ||||||||||||||||||||
| Term debt, related party | ||||||||||||||||||||
| Current portion of debt, related parties | ||||||||||||||||||||
| Current portion of operating lease obligations | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term portion of operating lease obligations | ||||||||||||||||||||
| Long-term line of credit – inventory, related party | ||||||||||||||||||||
| Long-term debt, related party | ||||||||||||||||||||
| Long-term portion of deferred revenue | ||||||||||||||||||||
| Asset retirement obligations | ||||||||||||||||||||
| Total long-term liabilities | ||||||||||||||||||||
| Series X convertible preferred stock: 15,000 and 0 shares, designated, issued and outstanding and liquidation preference of $6,000 from preferred stock in Shareholders’ equity on March 31, 2024 and December 31, 2023, respectively | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Common stock, $.01 par value, 95,000,000 shares authorized; 70,647,045 and 70,614,045 shares issued and outstanding on June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
